Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Revenue | 4.04B | 3.45B | 3.28B | 3.03B | 2.71B | 2.63B |
| Cost of revenue | 1.99B | 1.69B | 1.62B | 1.50B | 1.37B | 1.39B |
| Research and development | 398M | 355M | 351M | 306M | 289M | 303M |
| Selling, general and administrative | 432M | 400M | 388M | 332M | 315M | 494M |
| Operating expenses | 3.89B | 3.19B | 3.12B | 2.88B | 2.60B | 2.83B |
| Operating income | 151M | 258M | 163M | 155M | 107M | −201M |
| Pre-tax income | 191M | 248M | 271M | 198M | 155M | −157M |
| Income tax | 8M | 5M | −13M | 6M | −6M | 1M |
| Net income | 184M | 244M | 285M | 193M | 162M | −157M |
| Earnings per share | 0.42 | 0.57 | 0.67 | 0.46 | 0.39 | −0.38 |
| Earnings per share, diluted | 0.42 | 0.55 | 0.65 | 0.44 | 0.38 | −0.38 |
| Weighted average shares | 435M | 429M | 425M | 421M | 413M | 410M |
| Weighted average shares, diluted | 442M | 442M | 438M | 436M | 428M | 410M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.58B | 4.38B | 3.28B | 3.91B | 4.50B | 4.02B | 3.66B | 3.43B |
| Receivables | 1.03B | 1.11B | 894M |
| Metric | 31 Mar 2026 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | 594M | — | — | 635M | — | — |
| Depreciation and amortisation | 269M | 169M | 159M | 152M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 840M |
| 782M |
| 732M |
| 622M |
| 585M |
| Current assets | 8.59B | 8.64B | 10.49B | 9.74B | 7.85B | 7.39B | 6.76B | 6.62B |
| Goodwill | 5.50B | 5.52B | 3.57B | 3.53B | 2.41B | 2.32B | 2.46B | 2.37B |
| Total assets | 19.71B | 19.66B | 17.97B | 16.95B | 13.57B | 12.85B | 12.28B | 11.84B |
| Current liabilities | 6.03B | 6.15B | 5.13B | 4.70B | 4.58B | 4.44B | 4.09B | 4.03B |
| Total liabilities | 9.50B | 9.61B | 8.46B | 8.02B | 5.18B | 5.04B | 4.70B | 4.67B |
| Equity | 10.20B | 10.03B | 9.50B | 8.92B | 8.39B | 7.80B | 7.57B | 7.16B |
| 138M |
| 140M |
| Share-based compensation | 231M | — | — | 235M | — | — |
| Capital expenditure | 57M | — | — | 74M | — | — |
| Investing cash flow | −98M | — | — | −160M | — | — |
| Share buybacks | 162M | — | — | 0 | — | — |
| Financing cash flow | −173M | — | — | 3M | — | — |